All Stories

  1. Aging mitochondria in the context of SARS-CoV-2: exploring interactions and implications
  2. HIV Modulates Osteoblast Differentiation via Upregulation of RANKL and Vitronectin
  3. SARS-CoV-2 Modulation of HIV Latency Reversal in a Myeloid Cell Line: Direct and Bystander Effects
  4. Bystander Effects and Profibrotic Interactions in Hepatic Stellate Cells during HIV and HCV Coinfection
  5. The abortive SARS‐CoV‐2 infection of osteoclast precursors promotes their differentiation into osteoclasts
  6. HIV-Infected Hepatic Stellate Cells or HCV-Infected Hepatocytes Are Unable to Promote Latency Reversal among HIV-Infected Mononuclear Cells
  7. Molecular mechanisms underlying SARS-CoV-2 hepatotropism and liver damage
  8. Anticipating the future of the COVID-19 pandemic: insights into the emergence of SARS-CoV-2 variant JN.1 and its projected impact on older adults
  9. The interplay of aging, adipose tissue, and COVID-19: a potent alliance with implications for health
  10. Editorial: Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways
  11. B. abortus Infection Promotes an Imbalance in the Adipocyte–Osteoblast Crosstalk Favoring Bone Resorption
  12. Molecular mechanisms implicated in SARS-CoV-2 liver tropism
  13. Poliomyelitis is a current challenge: long-term sequelae and circulating vaccine-derived poliovirus
  14. HIV‐induced bystander cell death in astrocytes requires cell‐to‐cell viral transmission
  15. Henipaviruses: an expanding global public health concern?
  16. Monkeypox: considerations for the understanding and containment of the current outbreak in non-endemic countries
  17. SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients
  18. Editorial: Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans
  19. Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load
  20. Proinflammatory Microenvironment During Kingella kingae Infection Modulates Osteoclastogenesis
  21. Biological Characterization of Hepatitis B virus Genotypes: Their Role in Viral Replication and Antigen Expression
  22. Influence of aging on T cell response and renin-angiotensin system imbalance during SARS-CoV-2 infection
  23. Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors
  24. Mitochondrial Dynamics and VMP1-Related Selective Mitophagy in Experimental Acute Pancreatitis
  25. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
  26. Apoptosis in infectious diseases as a mechanism of immune evasion and survival
  27. Longitudinal characterization of HIV-1 pol-gene in treatment-naïve men-who-have-sex-with-men from acute to chronic infection stages
  28. Antioxidant and neuroprotective effects of mGlu3 receptor activation on astrocytes aged in vitro
  29. Priming Astrocytes With HIV-Induced Reactive Oxygen Species Enhances Their Trypanosoma cruzi Infection
  30. In vivo drug resistance mutation dynamics from the early to chronic stage of infection in antiretroviral-therapy-naïve HIV-infected men who have sex with men
  31. Brucella abortus Infection Modulates 3T3-L1 Adipocyte Inflammatory Response and Inhibits Adipogenesis
  32. Influence of HIV Infection and Antiretroviral Therapy on Bone Homeostasis
  33. Editorial: Advances in Liver Inflammation and Fibrosis Due to Infectious Diseases
  34. An evaluation of the SARS-CoV-2 epidemic 16 days after the end of social confinement in Hungary
  35. Hepatic Stellate Cells and Hepatocytes as Liver Antigen-Presenting Cells during B. abortus Infection
  36. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis
  37. Brucella abortus Infection Elicited Hepatic Stellate Cell-Mediated Fibrosis Through Inflammasome-Dependent IL-1β Production
  38. Advances in Liver Inflammation and Fibrosis due to Infectious Diseases
  39. Are the mechanisms involved in astrocyte and lymphocyte death during HIV infection similar?
  40. Cell Death Is Counteracted by Mitophagy in HIV-Productively Infected Astrocytes but Is Promoted by Inflammasome Activation Among Non-productively Infected Cells
  41. LT-CD4+ cell modulation of natural killer cells is not compromised in hepatitis C/human immunodeficiency virus-coinfected patients with advanced liver fibrosis
  42. Genomic characterization and molecular evolution analysis of subtype B and BF recombinant HIV-1 strains among Argentinean men who have sex with men reveal a complex scenario
  43. Astrocyte Apoptosis and HIV Replication Are Modulated in Host Cells Coinfected with Trypanosoma cruzi
  44. Phylogenetic Diversity in Core Region of Hepatitis C Virus Genotype 1a as a Factor Associated with Fibrosis Severity in HIV-1-Coinfected Patients
  45. CD4+ T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patients
  46. Evolution of hepatitis C virus in HIV coinfected patients under antiretroviral therapy
  47. Hepatitis B virus resistance substitutions: long-term analysis by next-generation sequencing
  48. 9LB HIV-1 disrupts mitochondrial dynamics: induces fission and mitophagy to attenuate apoptosis in astrocyte
  49. Virus evolution during chronic hepatitis B virus infection as revealed by ultradeep sequencing data
  50. Hepatitis C virus strategies to evade the specific-T cell response: a possible mission favoring its persistence
  51. Previous failure of interferon-based therapy does not alter the frequency of HCV NS3 protease or NS5B polymerase inhibitor resistance-associated variants: longitudinal analysis in HCV/HIV co-infected patients
  52. Corrigendum to “Inter and intra-host variability of hepatitis C virus genotype 1a hypervariable envelope coding domains followed for a 4–11 year of human immunodeficiency virus coinfection and highly active antiretroviral therapy” [Virology 471–473 (20...
  53. Inter and intra-host variability of hepatitis C virus genotype 1a hypervariable envelope coding domains followed for a 4–11 year of human immunodeficiency virus coinfection and highly active antiretroviral therapy
  54. MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro
  55. HIV-1 Tropism Dynamics and Phylogenetic Analysis from Longitudinal Ultra-Deep Sequencing Data of CCR5- and CXCR4-Using Variants
  56. Core promoter: A critical region where the hepatitis B virus makes decisions
  57. Increased in vitro glial fibrillary acidic protein expression, telomerase activity, and telomere length after productive human immunodeficiency virus‐1 infection in murine astrocytes
  58. Hepatitis B virus depicts a high degree of conservation during the immune‐tolerant phase in familiarly transmitted chronic hepatitis B infection: deep‐sequencing and phylogenetic analysis
  59. HIV, HBV, and HCV molecular epidemiology among trans (transvestites, transsexuals, and transgender) sex workers in Argentina
  60. Analysis of sequences of hepatitis C virus NS5A genotype 1 in HIV-coinfected patients with a null response to nitazoxanide or peg-interferon plus ribavirin
  61. Longitudinal HIV-1 gp120-C2V3C3 phylogenetic surveillance and tropism evolution in patients under HAART
  62. Mother-to-Child Transmission of Hepatitis C Virus (HCV) Among HIV/HCV-Coinfected Women
  63. Longitudinal analysis of the 5′UTR, E2-PePHD and NS5A-PKRBD genomic regions of hepatitis C virus genotype 1a in association with the response to peginterferon and ribavirin therapy in HIV-coinfected patients
  64. HIV-1 Induces Telomerase Activity in Monocyte-Derived Macrophages, Possibly Safeguarding One of Its Reservoirs
  65. Long-term monitoring drug resistance by ultra-deep pyrosequencing in a chronic hepatitis B virus (HBV)-infected patient exposed to several unsuccessful therapy schemes
  66. Comparative analysis of hepatitis B virus genotype a molecular evolution in patients infected with HBV and in patients co‐infected with HBV and HIV
  67. A clustering phenomenon among HCV‐1a strains among patients coinfected with HIV from Buenos Aires, Argentina
  68. Analysis of the PKR-eIF2alpha phosphorylation homology domain (PePHD) of hepatitis C virus genotype 1 in HIV-coinfected patients by ultra-deep pyrosequencing and its relationship to responses to pegylated interferon-ribavirin treatment
  69. No reduction of HCV viral load in HIV patients co-infected with HCV genotype 1 during a 30days course of nitazoxanide monotherapy
  70. Unsuccessful therapy with adefovir and entecavir-tenofovir in a patient with chronic hepatitis B infection with previous resistance to lamivudine: a fourteen-year evolution of hepatitis B virus mutations
  71. Short Communication: Hepatitis B Virus Harboring Nucleotide Deletions in the Basal Core Promoter in HBe-Positive HIV-Coinfected Patients Under Lamivudine Therapy
  72. Molecular characterization of hepatitis C virus genotype 4 sequences in HIV‐coinfected patients from Argentina
  73. HCV RNA decline in the first 24h exhibits high negative predictive value of sustained virologic response in HIV/HCV genotype 1 co-infected patients treated with peginterferon and ribavirin
  74. The Hepatitis C Virus 5′UTR Genomic Region Remains Highly Conserved Under HAART: A 4- to 8-Year Longitudinal Study from HCV/HIV Co-Infected Patients
  75. Hepatitis B Virus, Hepatitis C Virus and HIV Coinfection Among People Living With HIV/AIDS in Buenos Aires, Argentina
  76. Telomerase activity in peripheral blood mononuclear cells from HIV and HIV–HCV coinfected patients
  77. Hepatitis B precore/core promoter mutations in isolates from HBV-monoinfected and HBV–HIV coinfected patients: A 3-yr prospective study
  78. Evaluation of minority populations of HIV type-1 with K103N and M184V drug resistance mutations among children in Argentina
  79. Uncommon Hepatitis B Virus and/or Hepatitis C Virus Occult Infection in HIV-Positive Patients With Abnormal Level of Hepatic Enzyme
  80. Analysis of Sequence Configurations of the PKR-Interacting HCV Proteins from Plasma and PBMC as Predictors of Response to Interferon-Alpha and Ribavirin Therapy in HIV-Coinfected Patients
  81. Molecular characterization of hepatitis A virus in children with fulminant hepatic failure in Argentina
  82. Molecular characterization of hepatitis A virus isolates from Argentina
  83. Hepatitis B Virus Genotype Distribution and Its Lamivudine-Resistant Mutants in HIV-Coinfected Patients with Chronic and Occult Hepatitis B
  84. HIV-1 Infection Downregulates Nuclear Telomerase Activity on Lymphoblastoic Cells Without Affecting the Enzymatic Components at the Transcriptional Level
  85. HIV Type 1 BF Recombinant Strains Exhibit Different pol Gene Mosaic Patterns: Descriptive Analysis from 284 Patients under Treatment Failure
  86. Drug Resistance Testing Provides Evidence of the Globalization of HIV Type 1: A New Circulating Recombinant Form
  87. Differences in Frequencies of Drug Resistance???Associated Mutations in the HIV-1 pol Gene of B Subtype and BF Intersubtype Recombinant Samples
  88. Phylogenetic and Mathematical Analyses for Investigating Putative Mother-to-Infant Transmission Chains When Only GB Virus C (Hepatitis G Virus) 5' Noncoding Region Sequences Are Available
  89. In Vitro Detection of Dissimilar Amounts of Hepatitis C Virus (HCV) Subtype-Specific RNA Genomes in Mixes Prepared from Sera of Persons Infected with a Single HCV Genotype
  90. Hepatitis B virus S gene mutants in a patient with chronic active hepatitis with circulating Anti‐HBs antibodies
  91. HIV Type 1 Genetic Diversity Is a Major Obstacle for Antiretroviral Drug Resistance Hybridization-Based Assays
  92. Hepatitis C Virus and GBV-C/Hepatitis G Virus in Argentine Patients with Porphyria Cutanea Tarda
  93. Genomic and Phylogenetic Analysis of Hepatitis C Virus Isolates from Argentine Patients: a Six-Year Retrospective Study
  94. Genetic diversity of GBV-C/HGV strains among HIV infected-IVDU and blood donors from Buenos Aires, Argentina
  95. GB Virus C/Hepatitis G Virus Groups and Subgroups: Classification by a Restriction Fragment Length Polymorphism Method Based on Phylogenetic Analysis of the 5′ Untranslated Region